← Leaderboards
Elise N Erickson
Oregon Health & Science University
$3,518,736
Attributed
$3,675,326
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2020–25$2M$1.5M$1M$500K$0
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,675,326 · 4
By mechanism
R01$2,427,305 · 1
R00$746,627 · 1
R41$313,180 · 1
K99$188,214 · 1
Top collaborators
- Chinmai Basavaraj1 shared
Most similar at Oregon Health & Science University
Same institution · by research overlap
- Yali Jia$6,803,157
- Thomas Hwang$1,507,875
- Holly B Jimison$1,247,309
Others in their field
Other Emerging Leaders on “Maternal Morbidity”
- Chanza Baytop · Westat, Inc.$271,217,917
- Rebecca Feldman Hamm · University Of Pennsylvania$7,259,042
- Laura Hammitt · White Mountain Apache Tribe$6,892,308
- Akila Subramaniam · University Of Alabama At Birmingham$6,547,544
- Elliott K Main · Stanford University$5,767,517
- Hudson Santos · Univ Of North Carolina Chapel Hill$5,524,209
Research focus
Maternal MorbidityMothersInduced LaborCesarean SectionBirthSamplingPregnancyBiological MarkersPhenotypeMaternal HealthPersonsBlood SpecimenLinkPostpartum HemorrhageMorbidity - Disease RateGene ExpressionEnvironmentDna MethylationEpigenetic MarkerEpigenetic ProcessHigh RiskMaternal MortalityChildbirthMyometrial
Grant awards (10)
Oxytocin sensitivity and postpartum hemorrhage: testing genetic and epigenetic biomarkers for improving maternal morbidity$898,326
R01 · FY2025 · HD · contact PI
Accurate and actionable prediction of impending labor using deep learning on maternal physiological data$313,180
R41 · FY2025 · HD
Oxytocin sensitivity and postpartum hemorrhage: testing genetic and epigenetic biomarkers for improving maternal morbidity$628,243
R01 · FY2024 · HD · contact PI
Oxytocin sensitivity and postpartum hemorrhage: testing genetic and epigenetic biomarkers for improving maternal morbidity$288,649
R01 · FY2024 · HD · contact PI
The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy$248,630
R00 · FY2024 · NR · contact PI
Oxytocin sensitivity and postpartum hemorrhage: testing genetic and epigenetic biomarkers for improving maternal morbidity$612,087
R01 · FY2023 · HD · contact PI
The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy$249,000
R00 · FY2023 · NR · contact PI
The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy$248,997
R00 · FY2022 · NR · contact PI
The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy$94,106
K99 · FY2021 · NR · contact PI
The Clock is Ticking: Epigenetic Age Acceleration as a Biomarker of Uterine Function in Pregnancy$94,108
K99 · FY2020 · NR · contact PI